August 2021
Sanford Burnham Prebys drug enters Phase I study for the treatment of tobacco use disorder

A drug discovered in the lab of Nicholas Cosford, Ph.D., professor and deputy director of the NCI-designated Cancer Center at Sanford Burnham Prebys, has entered a Phase I clinical study. The compound, SBP-9330, targets a neuronal signaling pathway underlying addictive behaviors and would be a first-in-class oral therapeutic to help people quit smoking. The goal of the study is to determine the safety, tolerability and pharmacokinetic profile of SBP-9330 in humans and a safe dose for further clinical development.

USC Norris Cancer Center announces collaborative partnership with Sanford Burnham Prebys

Under the terms of a newly formed strategic partnership, USC researchers will collaborate with scientists at our Institute's Conrad Prebys Center for Chemical Genomics (Prebys Center) to transition clinically relevant cancer targets to early-stage drug discovery. "We are looking forward to working with USC to develop innovative screens to identify drugs that can potentially improve the outcomes of people living with cancer," says Michael Jackson, Ph.D., senior vice president of Drug Discovery and Development at the Prebys Center.

A look inside the lab: Researching breast cancer

Breast cancer affects one in eight American women. How are scientists working to improve treatments and save the lives of people with the disease? Join us on Tuesday, September 21, from 1:00 to 2:00 p.m. PT, to learn how the Haricharan Lab is advancing potential therapies for breast cancer.

Personalizing medicine for pediatric brain cancer

Medulloblastoma is the most common malignant brain tumor in children. Safer and more effective therapies are desperately needed, and advances cannot come soon enough. Join us on Tuesday, October 12, from 1:00 to 2:00 p.m. PT, to learn about the latest efforts to develop better treatments for pediatric brain cancer.

Stem Cells: The future is now

It wasn’t long ago when we first heard about the promise of stem cells. They were the wave of the future. We are now on the path to reap the benefits of breakthrough research to improve human health. Hear from Evan Snyder, M.D., Ph.D., on how stem cells are on the forefront of treatments and cures for diabetes, Parkinson’s disease, ALS, autoimmune diseases, heart disease, osteoarthritis and so many other health conditions that negatively affect our lives.

At Sanford Burnham Prebys, we're passionate about finding bold new ways to treat disease, and we recognize the importance of sharing our discoveries with the public—especially during this unprecedented time. Find out where and when you can "meet" our scientists virtually and learn about their research in this community event calendar.
Please Donate
Donate now

Please join Sanford Burnham Prebys as a partner in discovery. Our world-class research programs are dedicated to finding cures for human disease to help individuals and their families. Your gift helps our scientists advance medical research to save lives. 
Could you benefit from the CARES Act of 2020?

The CARES Act of 2020 offers a once-in-a-lifetime opportunity to make transformative philanthropic gifts, with significant tax benefits to you and your family. Cash gifts to charities such as Sanford Burnham Prebys are deductible at 100% of adjusted gross income.